Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 79.67%
March 31, 2026 84.85%
December 31, 2025 81.82%
September 30, 2025 83.06%
June 30, 2025 76.22%
March 31, 2025 81.01%
December 31, 2024 75.13%
September 30, 2024 85.32%
June 30, 2024 84.69%
March 31, 2024 85.39%
December 31, 2023 83.47%
September 30, 2023 82.16%
June 30, 2023 82.03%
March 31, 2023 82.58%
December 31, 2022 79.83%
September 30, 2022 80.25%
June 30, 2022 81.48%
March 31, 2022 78.72%
December 31, 2021 73.99%
September 30, 2021 77.54%
June 30, 2021 79.06%
March 31, 2021 80.45%
December 31, 2020 67.68%
September 30, 2020 82.68%
June 30, 2020 74.92%
Date Value
March 31, 2020 55.22%
December 31, 2019 68.12%
September 30, 2019 63.65%
June 30, 2019 57.55%
March 31, 2019 60.76%
December 31, 2018 70.74%
September 30, 2018 57.96%
June 30, 2018 73.76%
March 31, 2018 77.87%
December 31, 2017
September 30, 2017 73.90%
June 30, 2017 71.96%
March 31, 2017 47.47%
December 31, 2016 0.00%
September 30, 2016 71.96%
June 30, 2016 42.89%
March 31, 2016 3.81%
December 31, 2015 35.41%
September 30, 2015 73.56%
June 30, 2015 26.35%
March 31, 2015 44.64%
December 31, 2014 0.00%
September 30, 2014 56.74%
June 30, 2014 6.82%
March 31, 2014 -10.76%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Retrieve Medical Holdings, Inc. --
eXoZymes, Inc. --
HeartFlow, Inc. 83.00%
ACADIA Pharmaceuticals, Inc. 90.81%
Agenus, Inc. 98.50%

Gross Profit Margin (Quarterly) Related Metrics